MHRA Guidance on Borderline Products Updated MHRA Guidance on Borderline Products Updated The MHRA has updated their guidance ‘Borderline products: how to tell if your product... MHRA Guidance on Borderline Products Updated
CMDh November 2022 Meeting – Report CMDh November 2022 Meeting – Report The Co-ordination group for Mutual recognition and Decentralised procedures – human (CMDh) has published... CMDh November 2022 Meeting – Report
EMA System Demo: Q&A Documents Published EMA System Demo: Q&A Documents Published Following up on the three System Demos that took place in March, June and... EMA System Demo: Q&A Documents Published
MHRA Publishes Access Consortium Good Manufacturing Practice (GMP) Statement MHRA Publishes Access Consortium Good Manufacturing Practice (GMP) Statement In alignment with the Access Consortium’s strategic objective to expand and... MHRA Publishes Access Consortium Good Manufacturing Practice (GMP) Statement
MHRA Consultation on Proposals to Increase Statutory Fees – PAGB Response MHRA Consultation on Proposals to Increase Statutory Fees – PAGB Response MHRA is seeking views on proposals for changes to... MHRA Consultation on Proposals to Increase Statutory Fees – PAGB Response
HMPWG Meeting Report – May 2022 HMPWG Meeting Report – May 2022 The Heads of Medicines Agencies (HMA) Homeopathic Medicinal Products Working Group (HMPWG) has published... HMPWG Meeting Report – May 2022
EMRN Webinar – Draft Data Quality Framework for EU Medicines Regulation EMRN Webinar – Draft Data Quality Framework for EU Medicines Regulation The European Medicines Regulatory Network (EMRN) has... EMRN Webinar – Draft Data Quality Framework for EU Medicines Regulation
Draft EU Monograph on Fumaria officinalis L., herba – Consultation Draft EU Monograph on Fumaria officinalis L., herba – Consultation Further to its adoption by the EMA Committee on Herbal... Draft EU Monograph on Fumaria officinalis L., herba – Consultation
MHRA Guidance on Pharmacovigilance Procedures Updated MHRA Guidance on Pharmacovigilance Procedures Updated The MHRA has updated their guidance on Pharmacovigilance Procedures which summarises MHRA’s approach to... MHRA Guidance on Pharmacovigilance Procedures Updated
MHRA Board Meeting – 15 November 2022 MHRA (Medicines and Healthcare products Regulatory Agency) Board Meeting – 15 November 2022 The MHRA Board will meet in public... MHRA Board Meeting – 15 November 2022
Water Framework Directive Proposal Published Water Framework Directive Proposal Published The European Commission (EC) is proposing stronger rules on ambient air, surface and groundwater pollutants,... Water Framework Directive Proposal Published
MHRA Delivery Plan 2021-2023 – Updates for Year Two MHRA Delivery Plan 2021-2023 – Updates for Year Two The Delivery Plan 2021-2023 ‘Putting patients first; A... MHRA Delivery Plan 2021-2023 – Updates for Year Two
